Plain-language definitions grounded in the clinical and regulatory literature.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Military Pharmacology
What it isMilitary slang for prescribed sleep aids used to ensure rest during operational sleep windows. The complement to go-pills (stimulants used for wakefulness).
Why it mattersWhen operational schedules force sleep at biologically inconvenient times, no-go pills help personnel actually sleep during the assigned window, preserving function during the next operational period.
Think of it like thisOperations force sleep when your body doesn’t want it. Go-pills force wakefulness when your body wants sleep. No-go pills do the reverse, they impose sleep on a body that’s still wired from the mission.
Military operational pharmacology term for short-acting sedative-hypnotics used to induce sleep during scheduled rest periods that conflict with circadian phase. Historically dominated by zaleplon and zolpidem; current options include broader benzodiazepine receptor agonists and selective orexin receptor antagonists.
MechanismNo-go pills target either GABA-A receptors (zaleplon, zolpidem) or orexin receptors (suvorexant, lemborexant) to produce rapid sleep onset and short duration of action. The short half-life is operationally important to avoid residual sedation during the next operational period. Aviation and special operations protocols specify approved agents, doses, and minimum time-from-dose-to-flight.
Scientific ConsensusApproved no-go pills for military aviation and special operations use are restricted to specific agents with characterized operational profiles. Zaleplon and zolpidem are the most established. Use requires command authorization and ground testing for individual response before operational deployment.
Active DebateComparative efficacy and safety of GABA-A agonists vs orexin antagonists for operational sleep. The risk-benefit of no-go pill use during sustained operations vs strategic napping alone. Long-term effects of repeated use in operational personnel.
Emerging ResearchOrexin receptor antagonists (suvorexant, lemborexant) being evaluated for operational use given reduced abuse potential and absence of muscle relaxation effects. Personalized dosing based on individual chronotype and current circadian phase.
Key ResearchCaldwell and colleagues at the U.S. Army Aeromedical Research Laboratory established the operational pharmacology framework. AFI 11-202V3 and Navy aviation guidance specify approved agents and protocols. Reviews by Mysliwiec, Caldwell, and others outline operational best practices.
Caldwell, J.A., Caldwell, J.L. (2005). Fatigue in military aviation: an overview of US military-approved pharmacological countermeasures. Aviat Space Environ Med, 76(7 Suppl), C39-51.
— Foundational paper on US military operational pharmacology including no-go pills
— Modern military sleep medicine including operational pharmacology
Sleep disorders, PTSD, and the invisible wounds of service can feel isolating. If you or someone you know is in crisis or experiencing thoughts of self-harm, help is available right now. The Veterans Crisis Line provides free, confidential support 24 hours a day, 7 days a week to veterans, service members, and their families.
If you are in crisis or experiencing thoughts of self-harm, call the Veterans Crisis Line at